Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097523 · ClinicalTrials.gov registry record · NA
Mitigating Cephalad Fluid Shifts: A NSBRI Study
A NA study, sponsored by Saint John's Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03097523: Completed NA study, sponsored by Saint John's Cancer Institute.
NCT03097523 is a NA study that has completed, run by Saint John's Cancer Institute. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03097523, a NA study, has completed, sponsored by Saint John's Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a feasibility study to determine optimal thigh cuff design using a cephalad fluid shift protocol in patients who have an intraventricular catheter (such as Ommaya reservoir) placed for the delivery of central nervous system chemotherapy or for diagnosing potential elevation of ICP and monitoring its progression as part of standard medical care.
Primary Outcome
Noninvasive and invasive ICP monitoring following standard of care procedures requiring access to ventricular catheter
Interventions
- DEVICE Custom Thigh Cuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2017-05-31 |
| Phase | NA |
What the finished NCT03097523 record still lists
NCT03097523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Custom Thigh Cuff is the first listed.
NCT03097523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03097523 about?
NCT03097523 is a clinical study titled "Mitigating Cephalad Fluid Shifts: A NSBRI Study". This is a feasibility study to determine optimal thigh cuff design using a cephalad fluid shift protocol in patients who have an intraventricular catheter (such as Ommaya reservoir) placed for the delivery of central nervous system chemotherapy or for diagnosing potential elevation of ICP and monito...
What is the current status of trial NCT03097523?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2017-01-01. Estimated completion is 2017-05-31.
What interventions are being tested in trial NCT03097523?
The interventions under investigation include: Custom Thigh Cuff (DEVICE).
Who is sponsoring clinical trial NCT03097523?
This trial is sponsored by Saint John's Cancer Institute, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03097523's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI